This new position paper proposes 5 pre-defined business priorities to help pharma affiliates adjust to the changes of HCPs expectations, so that to keep them engaged in the post-Covid-19 era.
News
This 2nd position paper of our 2023 Medical Series proposes 5 recommendations and several tools to develop High-Performance...
In this position paper – the first of our 2023 Medical Series – we provide insights and...
In this position paper we have selected and analyzed 5 key topics that are specific to the...